Galinpepimut-S (GPS)

Galinpepimut-S · Sellas Life Sciences Group

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Galinpepimut-S (GPS), covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS